GDRX Q2 2022 Earnings — GoodRx Holdings, Inc. Revenue & Financial Results | Market Cap Arena

GDRXGoodRx Holdings, Inc.

$829M

Q2 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$192M+8.6% YoY

Gross Profit

$174M90.6% margin

Operating Income

-$4M-2.1% margin

Net Income

-$1M-0.7% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

-5.7%

Cash Flow

Operating Cash Flow

$51M

Free Cash Flow

$37M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$774M

Stockholders' Equity

$818M

Cash & Equivalents

$731M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$192M	$177M	+8.6%
Gross Profit	$174M	$166M	+5.0%
Operating Income	-$4M	-$351,000	-1053.0%
Net Income	-$1M	$31M	-104.6%

Revenue Segments

Prescription Transactions Revenue

$134M70%

Pharma Manufacturer Solutions Revenues

$27M14%

Subscription Revenue

$26M14%

Other Revenue

$5M3%